China's healthcare market, the world's second largest, shows strong growth potential yet remains a policy-intensive landscape. Agile, localised data offers a chance at investment success in an ecosystem distinct from global norms. We consider some of the key data providers that can help.

China’s healthcare market

China’s healthcare expenditure is expected to reach RMB 205tn by 2030, driven in large by a rapidly ageing population; it is estimated 450m people will be over 60 by 2035. As chronic diseases become more common, demand for healthcare services is expanding. In 2024, China led the world in clinical trial volume, according to GlobalData. These trends highlight strong government backing for innovation and regulatory reform, creating a fertile environment for long-term investment.